{
    "id": "20260202_Genetic an",
    "meta": {
        "title": "Genetic and epigenetic insights into perioperative neurocognitive disorders: a narrative review.",
        "summary": "Perioperative neurocognitive disorders (PND) remain a major clinical and public health challenge despite substantial scientific progress over the past two decades. Unidentified traits continue to limit the development of effective pharmacologic strategies and evidence-based care practices, particularly for high-risk patients. Emerging insights into the genetic and epigenetic architecture of PND are revealing novel mechanistic targets and paving the way toward precision approaches to perioperative brain health. Expanding biobanks and genome-wide association studies are accelerating the ability to explore genetic and epigenetic determinants of PND. Genetic factors influence key pathways associated with PND, particularly those involved in neurodegeneration, circadian rhythm dysregulation, and inflammation. Epigenetic mechanisms, including DNA methylation, histone modifications, and noncoding RNA activity, further link genetic susceptibility with environmental exposures and perioperative stressors, modulating immune activation and neurotransmission in ways that may predispose to PND. Unlike static genetic variants, epigenetic alterations are dynamic and potentially reversible, offering unique opportunities for biomarker discovery and therapeutic intervention. Insights from genetic and epigenetic discoveries can be aggregated into risk scores and integrated with other multi-omics approaches. In this narrative review, we summarise evidence linking genetic and epigenetic traits to PND and outline future directions for applying multi-omics approaches in the perioperative setting. Collectively, these advances are establishing the foundation for a precision medicine framework aimed at enhancing prediction, prevention, and management strategies to improve brain health.",
        "published": "2026",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41620312/",
        "source": "PubMed",
        "mapping_chapter": "動物生理 (Animal Physiology)",
        "mapping_keyword": "neurotransmission",
        "subject": "biology"
    },
    "content": "# 手術後的腦袋大迷航？遺傳與表觀遺傳學對「圍術期神經認知障礙」的深度解析\n\n## 1. 研究背景與課本關聯\n你有沒有聽過長輩在接受大手術後，雖然傷口復原良好，卻突然變得容易忘東忘西、注意力不集中，甚至出現性格大變的現象？這在醫學上稱為「圍術期神經認知障礙（PND）」。這項研究與高中生物「動物生理」章節中，關於**神經系統**的訊息傳導、**免疫系統**的發炎反應，以及選修生物中**基因表達的調節**（表觀遺傳學）密切相關。科學家正試圖解開：為什麼手術壓力會觸發大腦的發炎反應，進而影響神經元的正常功能？\n\n## 2. 核心發現\n這篇綜述論文指出，PND 的發生並非單一因素，而是個體的「遺傳背景」與「環境壓力」共同作用的結果。研究核心可以歸納為以下三個面向：\n\n首先是**遺傳因素（Genetic factors）**。科學家透過全基因組關聯分析（GWAS）發現，某些病患天生攜帶特定的基因變異，這些基因主要參與了**神經退化途徑**、**晝夜節律（生理時鐘）**的調控以及**發炎反應**。這解釋了為何在相同的麻醉與手術條件下，有些病患能迅速恢復，有些人卻會出現嚴重的認知功能下降。\n\n其次是**表觀遺傳機制（Epigenetic mechanisms）**，這是目前生物學最前沿的領域。研究發現，手術產生的生理壓力會透過 **DNA 甲基化**、**組蛋白修飾**以及**非編碼 RNA** 的活動，在不改變 DNA 序列的前提下，改變基因的開關狀態。這些表觀遺傳的變化會調節免疫細胞的活化，導致大腦內出現過度的發炎反應，進而干擾**神經傳導物質**的釋放與突觸塑性。\n\n最後，研究強調了表觀遺傳的「動態性」。與固定的基因序列不同，表觀遺傳修飾是**可逆的**。這為臨床醫學帶來了新希望：未來醫師可能透過檢測病患術前的表觀遺傳標記，計算出「風險評分」，並開發針對性的藥物來精準預防 PND 的發生。這正是「精準醫療」在圍術期腦健康保護上的具體應用，讓手術不再只是治癒身體的傷口，更能守護大腦的認知功能。\n\n---\n{\n    \"question\": \"根據本文內容與高中生物所學知識，關於「圍術期神經認知障礙 (PND)」與基因表達調節的敘述，下列何者最正確？\",\n    \"options\": [\n        \"(A) 表觀遺傳修飾（如 DNA 甲基化）會改變 DNA 的鹼基序列，進而導致神經蛋白功能異常\",\n        \"(B) 手術壓力可能透過組蛋白修飾影響基因表達，進而調節大腦內的發炎反應\",\n        \"(C) PND 的發生僅由環境因素（如麻醉藥物）決定，與個體的遺傳背景無關\",\n        \"(D) 非編碼 RNA 因為不參與蛋白質轉譯，因此在 PND 的病理生理過程中不具備任何功能\"\n    ],\n    \"correct_answer\": \"B\",\n    \"explanation\": \"(A) 表觀遺傳修飾（DNA 甲基化、組蛋白修飾）是在不改變 DNA 序列的情況下調節基因表達。(B) 正確，文中提到表觀遺傳機制（含組蛋白修飾）會連結環境壓力與免疫活化，影響 PND。(C) 文中明確指出 PND 受遺傳因素與環境因素共同影響。(D) 非編碼 RNA 是表觀遺傳調節的重要一環，會影響基因的表現量，與 PND 的發生有關。\"\n}",
    "processed_at": "2026-02-02 13:45:31"
}